KIMBERLY GONZALEZ: Open Payments
NPI 1902405533 · ALICE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 52 payments from 13 companies in 2025. Trend: 2023 $1,174 · 2024 $1,331 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $383 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $221 |
| Lilly USA, LLC | 5 | $141 |
| Exact Sciences Corporation | 3 | $55 |
| Astellas Pharma US Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| PFIZER INC. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Ozempic, Kerendia, MOUNJARO, Cologuard Collection Kit, Rybelsus, Veozah, XIFAXAN, OTEZLA.
Industry payments across TX — which companies pay providers there.
